Friday, July 14, 2006
Migenix develops CLS001 (formerly MX-594AN) as a topical treatment for rosacea
Migenix, using technology licensed and being developed in partnership with Cutanea Life Sciences, is developing a new topical product for rosacea. It looks to be an anti-inflammatory/anti-microbial (so may be beneficial for those rosacea sufferers with acne), based on "cationic antimicrobial peptides". Phase II trials are due to be completed in 2007.
Migenix's financial results and announcement of the rosacea topical (Yahoo)
Study on the active ingredient: "Anti-inflammatory activity of cationic peptides.."
One to keep an eye on, although I note that this topical was studies for use in Acne with Phase II trials in 2003... So it's curious they are looking at rosacea as the first indication.
Migenix's financial results and announcement of the rosacea topical (Yahoo)
Study on the active ingredient: "Anti-inflammatory activity of cationic peptides.."
One to keep an eye on, although I note that this topical was studies for use in Acne with Phase II trials in 2003... So it's curious they are looking at rosacea as the first indication.
